103890-78-4 Purity
99.79%
If you have any other questions or need other size, please get a quote.
Specification
The molecular formula of Amrubicin is C25H25NO9.
The molecular weight of Amrubicin is 483.5 g/mol.
Amrubicin is used in the treatment of cancer, particularly lung cancer, as a specific inhibitor of topoisomerase II.
Amrubicin is described as a topoisomerase II inhibitor, an antineoplastic agent, and a prodrug. It is a quinone, a member of tetracenes, a methyl ketone, an anthracycline antibiotic, and a primary amino compound.
Amrubicin was first created in August 2005 and was last modified in December 2023.
The IUPAC name of Amrubicin is (7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione.
The InChIKey of Amrubicin is VJZITPJGSQKZMX-XDPRQOKASA-N.
The Canonical SMILES of Amrubicin is CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N.
Some synonyms for Amrubicin include Amrubicin(SM-5887), 93N13LB4Z2, and Amrubicin [INN].
The ChEBI description of Amrubicin states that it is a synthetic anthracycline antibiotic currently in development for the treatment of small cell lung cancer.